This report evaluates Armata Pharmaceuticals, Inc. (ARMP) for Shariah compliance across financial, business activity, and governance dimensions. The analysis reveals significant challenges in financial screening due to high debt and interest income ratios, while business activities in biotechnology appear permissible. Overall, the company does not meet key Shariah thresholds, leading to a non-compliant status. Investors are advised to consider purification requirements and monitor financial improvements. Alternative compliant investments in healthcare are recommended.